摘要
我们以前报道了大电导率钙激活的钾(big-K,BK)通道的活性受到皮质锥体细胞中细胞内Aβ的抑制,且该抑制被3xTg老年痴呆模型小鼠中的支架蛋白Homer1a所逆转。已知,Homer1a也是因生理性光刺激(PS)被表达的。因此PS也可能逆转Aβ诱导的BK通道抑制而改善3xTg小鼠的认知能力。我们测试了其可能性。每日6小时持续4周的PS(频率,2 Hz;工作时间,约1/10;亮度,300lx)的长期应用改善了3xTg小鼠的与语境和声调相关的恐惧记忆,也较小程度地改善了其在Morris水迷宫中的表现。PS后,海马长期增强作用也被提高。环带皮层锥体细胞和侧杏仁体主细胞中的BK通道活性(在3xTg小鼠中被抑制)被促进。同时,神经元兴奋性(在3xTg小鼠中被提高)恢复至控制水平。BK通道和支架蛋白Homer1a的基因表达在3xTg小鼠中减少,并被PS逆转。已知,Homer1a是一种活性依赖性的可诱导的即时的早期基因产物。我们以前的发现始终显示:电刺激诱导的Homer1a促进了BK通道。通过敲除Homer1a,我们发现现在PS诱导的BK通道促进作用是Homer1a表达介导的。因此,我们推测PS可能成为老年痴呆的非侵入性治疗手段。
关键词: 老年痴呆,BK通道,认知能力改善,兴奋性,Homer1,光刺激。
Current Alzheimer Research
Title:Cognitive Improvement by Photic Stimulation in a Mouse Model of Alzheimer’s Disease
Volume: 12 Issue: 9
Author(s): Yu Zhang, Furong Wang, Xianwen Luo, Li Wang, Peng Sun, Min Wang, Yongsheng Jiang, Jingyu Zou, Osamu Uchiumi, Ryo Yamamoto and Tokio Sugai, Kenji Yamamoto and Nobuo Kato
Affiliation:
关键词: 老年痴呆,BK通道,认知能力改善,兴奋性,Homer1,光刺激。
摘要: We previously reported that activity of the large conductance calcium-activated potassium (big-K, BK) channel is suppressed by intracellular Aβ in cortical pyramidal cells, and that this suppression was reversed by expression of the scaffold protein Homer1a in 3xTg Alzheimer’s disease model mice. Homer1a is known to be expressed by physiological photic stimulation (PS) as well. The possibility thus arises that PS also reverses Aβ-induced suppression of BK channels, and thereby improves cognition in 3xTg mice. This possibility was tested here. Chronic application of 6-hour-long PS (frequency, 2 Hz; duty cycle, about 1/10; luminance, 300 lx) daily for 4 weeks improved contextual and tone-dependent fear memory in 3xTg mice and, to a lesser extent, Morris water maze performance as well. Hippocampal long-term potentiation was also enhanced after PS. BK channel activity in cingulate cortex pyramidal cells and lateral amygdalar principal cells, suppressed in 3xTg mice, were facilitated. In parallel, neuronal excitability, elevated in 3xTg mice, was recovered to the control level. Gene expression of BK channel, as well as that of the scaffold protein Homer1a, was found decreased in 3xTg mice and reversed by PS. It is known that Homer1a is an activity-dependently inducible immediate early gene product. Consistently, our previous findings showed that Homer1a induced by electrical stimulation facilitated BK channels. By using Homer1a knockouts, we showed that the present PS-induced BK channel facilitation is mediated by Homer1a expression. We thus propose that PS might be potentially useful as a non-invasive therapeutic measure against Alzheimer’s disease.
Export Options
About this article
Cite this article as:
Yu Zhang, Furong Wang, Xianwen Luo, Li Wang, Peng Sun, Min Wang, Yongsheng Jiang, Jingyu Zou, Osamu Uchiumi, Ryo Yamamoto and Tokio Sugai, Kenji Yamamoto and Nobuo Kato , Cognitive Improvement by Photic Stimulation in a Mouse Model of Alzheimer’s Disease, Current Alzheimer Research 2015; 12 (9) . https://dx.doi.org/10.2174/1567205012666150710115755
DOI https://dx.doi.org/10.2174/1567205012666150710115755 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Alzheimer's Disease Drug Development
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Despite decades of research, no cure or disease-modifying treatment is available yet. Therefore, the need for developing effective therapies to treat Alzheimer's disease is an urgent matter. This special issue aims to provide a comprehensive overview of ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer’s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Flavonoids as Natural Inhibitors of Jack Bean Urease Enzyme
Letters in Drug Design & Discovery Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Takotsubo Cardiomyopathy: What we have Learned in the Last 25 Years? (A Comparative Literature Review)
Current Cardiology Reviews The Beneficial Effect of Rice Bran Extract Against Rotenone-Induced Experimental Parkinson’s Disease in Rats
Current Molecular Pharmacology Phytol a Natural Diterpenoid with Pharmacological Applications on Central Nervous System: A Review
Recent Patents on Biotechnology Melatonin and Synthetic Melatonergic Agonists: Actions and Metabolism in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Triplication of <i>Synaptojanin 1</i> in Alzheimer’s Disease Pathology in Down Syndrome
Current Alzheimer Research Spatiotemporal Modulation of Central Neural Pathway Underlying Acupuncture Action: A Systematic Review
Current Medical Imaging ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design ABC Pumps and Their Role in Active Drug Transport
Current Topics in Medicinal Chemistry α7-Nicotinic Acetylcholine Receptors: An Old Actor for New Different Roles
Current Drug Targets Editorial [Is Suicidality Serious?]
Current Drug Safety CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors
Current Medicinal Chemistry Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status
Current Neuropharmacology Nonconvulsive (Dialeptic) Status Epilepticus in Children
Current Pediatric Reviews 5 Hz Repetitive Transcranial Magnetic Stimulation with Maximum Voluntary Muscle Contraction Facilitates Cerebral Cortex Excitability of Normal Subjects
CNS & Neurological Disorders - Drug Targets MicroRNA-542-3p Regulates P-glycoprotein Expression in Rat Epilepsy via the Toll-like Receptor 4/Nuclear Factor-kappaB Signaling Pathway
Current Neurovascular Research